Judges Scientific PLC (GB:JDG)
LSE:JDG
Top Page
Judges Scientific
(LSE:JDG)
Select Model
Select Model
Rating:69Neutral
Price Target:
5,470.00 p
▲(28.71% Upside)
Action:ReiteratedDate:12/07/25
Judges Scientific's strong financial performance and positive corporate events are significant strengths, contributing to a solid overall score. However, the stock's technical indicators suggest caution, and its high P/E ratio indicates potential overvaluation. The absence of recent earnings call data limits insights into current management sentiment and guidance.
Positive Factors
Cash generation
Judges Scientific demonstrates robust cash generation with growing free cash flow and a strong operating cash flow to net income ratio. This durable cash conversion supports reinvestment in R&D, funding of acquisitions, steady maintenance of service operations, and provides a buffer through business cycles over the next several quarters.
Negative Factors
EPS contraction
A roughly 26% decline in EPS signals meaningful pressure on earnings power, which may reflect margin compression, restructuring or integration costs. Sustained EPS weakness reduces internal funding capacity and raises the bar for operational improvements, creating a multi‑quarter headwind to profit expansion.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash generation
Judges Scientific demonstrates robust cash generation with growing free cash flow and a strong operating cash flow to net income ratio. This durable cash conversion supports reinvestment in R&D, funding of acquisitions, steady maintenance of service operations, and provides a buffer through business cycles over the next several quarters.
Read all positive factors
Judges Scientific (JDG) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£283.07M
Dividend Yield1.89%
Average Volume (3M)19.94K
Price to Earnings (P/E)31.2
Beta (1Y)0.92
Revenue Growth5.46%
EPS Growth-26.44%
CountryUK
Employees767
SectorTechnology
Sector Strength88
IndustryHardware, Equipment & Parts
Share Statistics
EPS (TTM)0.10
Shares Outstanding6,660,444
10 Day Avg. Volume25,550
30 Day Avg. Volume19,941
Financial Highlights & Ratios
PEG Ratio7.16
Price to Book (P/B)6.45
Price to Sales (P/S)4.20
P/FCF Ratio25.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£4,807.50Price Target Upside13.12% Upside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)2.04
Revenue Forecast (FY)£125.32M
Judges Scientific Business Overview & Revenue Model
Company Description
Judges Scientific plc designs, manufactures, and sells scientific instruments. The company operates through two segments, Materials Sciences and Vacuum. It offers engineering teaching and research equipment for universities, colleges, schools, and...
How the Company Makes Money
Judges Scientific generates revenue through the sale of its proprietary scientific instruments and equipment, as well as through ongoing maintenance and support services for these products. The company benefits from a diversified revenue model tha...
Judges Scientific Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
68
Positive
Cash Flow
75
Positive
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 143.00M | 133.60M | 136.10M | 113.21M | 91.29M | 79.86M |
| Gross Profit | 23.30M | 92.00M | 93.60M | 21.01M | 15.34M | 10.02M |
| EBITDA | 31.80M | 30.90M | 32.20M | 29.00M | 20.33M | 15.17M |
| Net Income | 11.00M | 10.40M | 9.50M | 12.50M | 12.68M | 8.22M |
Balance Sheet | ||||||
| Total Assets | 200.30M | 205.10M | 183.50M | 185.79M | 88.98M | 82.03M |
| Cash, Cash Equivalents and Short-Term Investments | 18.90M | 17.90M | 13.70M | 20.83M | 18.41M | 15.52M |
| Total Debt | 69.30M | 73.60M | 65.30M | 59.95M | 21.32M | 26.37M |
| Total Liabilities | 107.60M | 117.90M | 100.90M | 131.33M | 45.58M | 48.98M |
| Stockholders Equity | 92.50M | 86.90M | 82.40M | 54.24M | 42.78M | 32.19M |
Cash Flow | ||||||
| Free Cash Flow | 28.40M | 22.10M | 20.60M | 12.33M | 13.44M | 10.53M |
| Operating Cash Flow | 32.80M | 28.50M | 26.50M | 20.22M | 16.89M | 11.79M |
| Investing Cash Flow | -18.70M | -22.60M | -25.90M | -50.80M | -5.21M | -12.67M |
| Financing Cash Flow | -300.00K | -1.40M | -7.60M | 31.20M | -8.81M | 2.34M |
Judges Scientific Technical Analysis
Neutral
4250.00
Price Trends
4575.90
Negative
5031.25
Negative
5837.64
Negative
Market Momentum
-112.52
Negative
49.23
Neutral
68.75
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:JDG, the sentiment is Neutral. The current price of 4250 is above the 20-day moving average (MA) of 4053.25, below the 50-day MA of 4575.90, and below the 200-day MA of 5837.64, indicating a neutral trend. The MACD of -112.52 indicates Negative momentum. The RSI at 49.23 is Neutral, neither overbought nor oversold. The STOCH value of 68.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:JDG.
Judges Scientific Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £534.43M | 10.73 | 8.34% | 2.09% | 0.49% | 61.73% | |
73 Outperform | £65.18M | 3.57 | 22.93% | ― | 36.61% | ― | |
72 Outperform | £2.62B | 17.58 | 8.06% | 2.12% | 3.15% | -13.57% | |
69 Neutral | £283.07M | 31.22 | 12.26% | 1.89% | 5.46% | -26.44% | |
67 Neutral | £208.56M | 25.56 | 3.10% | 2.19% | 10.66% | 21.19% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £213.67M | -4.02 | -31.21% | ― | -16.33% | -448.12% |
* Technology Sector Average
GB:JDG
Judges Scientific
4,250.00
-2,529.68
-37.31%
GB:GHH
Gooch & Housego
762.00
390.57
105.15%
GB:KMK
Kromek Group plc
9.95
4.95
99.00%
GB:RSW
Renishaw
3,605.00
1,348.15
59.74%
GB:TTG
TT Electronics
120.00
42.00
53.85%
GB:DSCV
discoverIE Group plc
556.00
53.13
10.57%
Judges Scientific Corporate Events
Regulatory Filings and Compliance
Judges Scientific Updates Total Voting Rights to 6.66 Million Shares
Neutral
Feb 2, 2026
Judges Scientific plc has reported that its total issued share capital stood at 6,660,444 ordinary shares of 5p each as of 31 January 2026, with no shares held in treasury and each share carrying one voting right. This updated figure, which establ...
Regulatory Filings and Compliance
Judges Scientific CEO Exercises Share Options, Lifting Issued Share Capital and Voting Rights
Neutral
Jan 29, 2026
Judges Scientific plc has announced that its Chief Executive Officer, David Cicurel, has exercised options over 7,500 new ordinary shares, increasing his beneficial holding to 551,892 shares and his combined beneficial and non-beneficial interest ...
Business Operations and StrategyExecutive/Board Changes
Judges Scientific Grants New Share Options Tied to Earnings Growth Targets
Positive
Jan 29, 2026
Judges Scientific has granted options over 81,600 new ordinary shares under its 2025 share option schemes at an exercise price of £52.00, largely to its executive directors, as part of its policy to use equity incentives for retention and per...
Business Operations and StrategyFinancial Disclosures
Judges Scientific Cuts Earnings Expectations as US Funding and Offshore Wind Slow Demand
Negative
Jan 22, 2026
Judges Scientific has warned that trading in 2025 fell short of expectations, as uncertainty over US federal funding for scientific research and weaker demand from offshore wind hit order intake and earnings, particularly in the United States wher...
Other
Judges Scientific Executives Receive Shares Through Incentive Plan Purchases
Positive
Jan 8, 2026
Judges Scientific has disclosed a series of small share purchases in the company by trustees of its Share Incentive Plan on behalf of senior management, including the chief executive officer, chief financial officer, chief operating officer, group...
Business Operations and Strategy
Judges Scientific Executives Participate in Share Incentive Plan
Positive
Dec 9, 2025
Judges Scientific plc announced the purchase of ordinary shares by the Trustees of the Share Incentive Plan involving several key executives, including the CEO, CFO, COO, Group Business Development Director, and Group Commercial Director. The tran...
Financial DisclosuresM&A Transactions
Judges Scientific Acquires Remaining Stake in Geotek do Brasil
Positive
Dec 3, 2025
Judges Scientific has announced the acquisition of the remaining minority shareholding in its subsidiary Geotek do Brasil, which operates the core digitalisation business in Brazil. This acquisition, valued at an initial BRL13m (£1.9m), is ex...
Business Operations and StrategyExecutive/Board Changes
Judges Scientific Announces Leadership Transition to Ensure Continued Growth
Positive
Nov 26, 2025
Judges Scientific has announced a significant board succession plan effective from February 2026. Founder and CEO David Cicurel will transition to Non-Executive Chair, while Tim Prestidge, currently the Group Business Development Director, will ta...
Business Operations and StrategyDividends
Judges Scientific Executives Reinforce Commitment Through Share Purchases
Positive
Nov 13, 2025
Judges Scientific announced the purchase of ordinary shares by its Chief Financial Officer, Brad Ormsby, and Non-Executive Chairman, Ralph Elman, under an automatic dividend reinvestment program. This transaction, conducted on the London Stock Exc...
Business Operations and Strategy
Judges Scientific Executives Participate in Share Incentive Plan
Positive
Nov 11, 2025
Judges Scientific plc announced the purchase of ordinary shares by the Trustees of the Share Incentive Plan, involving key executives including the CEO, CFO, COO, Group Business Development Director, and Group Commercial Director. This transaction...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.